CEDNIK syndrome

CEDNIK syndrome
Synonyms	Cerebral dysgenesis, Neuropathy, Ichthyosis, and Keratoderma syndrome
Pronounce	N/A
Specialty	N/A
Symptoms	Neurological abnormalities, Ichthyosis, Palmoplantar keratoderma, Developmental delay
Complications	N/A
Onset	Infancy
Duration	Lifelong
Types	N/A
Causes	Genetic mutation in the SNAP29 gene
Risks	Autosomal recessive inheritance
Diagnosis	Genetic testing, Clinical evaluation
Differential diagnosis	Other genetic syndromes with similar symptoms
Prevention	N/A
Treatment	Symptomatic treatment, Supportive care
Medication	N/A
Prognosis	N/A
Frequency	Rare disease
Deaths	N/A

Rare genetic disorder

Template:Medical condition (new) CEDNIK syndrome is a rare genetic disorder characterized by a combination of neurological, cutaneous, and developmental abnormalities. The name "CEDNIK" is an acronym derived from the main features of the syndrome: Cerebral dysgenesis, Neuropathy, Ichthyosis, and Keratoderma.

Presentation

Individuals with CEDNIK syndrome typically present with a range of symptoms that affect multiple systems of the body. The most prominent features include:

• Cerebral dysgenesis: This refers to abnormal development of the brain, which can lead to microcephaly (a condition where the head is smaller than normal), seizures, and intellectual disability.
• Neuropathy: Affects the peripheral nervous system, leading to muscle weakness, sensory loss, and motor skill difficulties.
• Ichthyosis: A skin condition characterized by dry, scaly skin. This is a common feature in individuals with CEDNIK syndrome and can vary in severity.
• Keratoderma: Thickening of the skin on the palms of the hands and soles of the feet, which can lead to discomfort and difficulty with movement.

Genetics

CEDNIK syndrome is caused by mutations in the SNAP29 gene, which is located on chromosome 22. This gene is involved in the process of vesicle fusion in cells, which is crucial for the transport of molecules within cells and for the maintenance of cellular structures. Mutations in SNAP29 disrupt these processes, leading to the symptoms observed in CEDNIK syndrome. The syndrome is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. Parents of an affected individual are typically carriers of the condition, meaning they have one copy of the mutated gene but do not show symptoms themselves.

Diagnosis

Diagnosis of CEDNIK syndrome is based on clinical evaluation, identification of characteristic symptoms, and genetic testing to confirm mutations in the SNAP29 gene. Magnetic resonance imaging (MRI) of the brain may reveal structural abnormalities consistent with cerebral dysgenesis.

Management

There is currently no cure for CEDNIK syndrome, and treatment is primarily supportive and symptomatic. Management strategies may include:

• Physical therapy and occupational therapy to improve motor skills and enhance quality of life.
• Antiepileptic drugs to control seizures.
• Dermatological treatments to manage ichthyosis and keratoderma, such as moisturizing creams and keratolytic agents.
• Educational support and special education programs to address intellectual disabilities and learning difficulties.

Prognosis

The prognosis for individuals with CEDNIK syndrome varies depending on the severity of symptoms and the effectiveness of management strategies. Early intervention and comprehensive care can improve outcomes and quality of life for affected individuals.

Related pages

• Genetic disorder
• Neurological disorder
• Skin condition
• Intellectual disability